BioSyent Releases Q2 and H1 2017 Results - CORRECTION
August 16, 2017 10:45 ET
|
Biosyent
TORONTO, Aug. 16, 2017 (GLOBE NEWSWIRE) -- BioSyent Inc.’s (“BioSyent”) (TSX Venture:RX) press release issued at 8:00am ET on August 16, 2017 contained erroneous information regarding the grant of...
BioSyent Releases Q2 and H1 2017 Results
August 16, 2017 08:00 ET
|
Biosyent
TORONTO, Aug. 16, 2017 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”) (TSX Venture:RX) released today a summary of its financial results for the three and six months ended June 30, 2017. Key...
BioSyent Schedules Q2 and H1 2017 Earnings Release for August 16, 2017
August 08, 2017 08:00 ET
|
Biosyent
TORONTO, Aug. 08, 2017 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”) (TSX Venture:RX) will be reporting its financial results for the three and six months ended June 30, 2017 on Wednesday, August...
BioSyent Releases Q1 2017 Results
May 25, 2017 08:00 ET
|
BioSyent Inc.
TORONTO, ONTARIO--(Marketwired - May 25, 2017) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) released today a summary of its financial results for the three months ended March 31, 2017....
BioSyent Schedules Q1 2017 Earnings Release for May 25, 2017
May 16, 2017 08:00 ET
|
BioSyent Inc.
TORONTO, ONTARIO--(Marketwired - May 16, 2017) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) will be reporting its financial results for the three months ended March 31, 2017 on Thursday,...
FeraMAX(R) Named #1 by Canadian Physicians and Pharmacists for Second Consecutive Year
May 01, 2017 08:00 ET
|
BioSyent Inc.
TORONTO, ONTARIO--(Marketwired - May 1, 2017) - Editors note: There is one image accompanying this press release.
BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) is pleased to announce...
BioSyent to Present at 2017 Bloom Burton & Co. Healthcare Investor Conference
April 24, 2017 08:00 ET
|
BioSyent Inc.
TORONTO, ONTARIO--(Marketwired - April 24, 2017) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) is pleased to announce that it will be presenting at the upcoming Bloom Burton & Co....
BioSyent Extends In-License Agreement for Cathejell(R)
April 20, 2017 16:00 ET
|
BioSyent Inc.
TORONTO, ONTARIO--(Marketwired - April 20, 2017) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) is pleased to announce that its wholly-owned subsidiary, BioSyent Pharma Inc. ("BioSyent...
BioSyent Releases Results for Fourth Quarter and Full Year 2016
March 15, 2017 08:00 ET
|
BioSyent Inc.
TORONTO, ONTARIO--(Marketwired - March 15, 2017) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) released today a summary of its financial results for the three and twelve months ended...
BioSyent Schedules Fourth Quarter 2016 Earnings Release for March 15, 2017
March 06, 2017 08:00 ET
|
BioSyent Inc.
TORONTO, ONTARIO--(Marketwired - March 6, 2017) - BioSyent Inc. ("BioSyent", "the Company") (TSX VENTURE:RX) will be reporting its financial results for the fourth quarter and...